Targeting <scp>ASCT2</scp>‐mediated glutamine uptake blocks prostate cancer growth and tumour development
Targeting <scp>ASCT2</scp>‐mediated glutamine uptake blocks prostate cancer growth and tumour development is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Targeting <scp>ASCT2</scp>‐mediated glutamine uptake blocks prostate cancer growth and tumour development have?
Targeting <scp>ASCT2</scp>‐mediated glutamine uptake blocks prostate cancer growth and tumour development has 332 citations in the OpenAlex counts ScholarIQ stores.
When was Targeting <scp>ASCT2</scp>‐mediated glutamine uptake blocks prostate cancer growth and tumour development published?
Targeting <scp>ASCT2</scp>‐mediated glutamine uptake blocks prostate cancer growth and tumour development has 2015 year in the ScholarIQ index.
What is the open-access status of Targeting <scp>ASCT2</scp>‐mediated glutamine uptake blocks prostate cancer growth and tumour development?
Targeting <scp>ASCT2</scp>‐mediated glutamine uptake blocks prostate cancer growth and tumour development has hybrid oa status in the ScholarIQ index.
What is the DOI of Targeting <scp>ASCT2</scp>‐mediated glutamine uptake blocks prostate cancer growth and tumour development?
The DOI for Targeting <scp>ASCT2</scp>‐mediated glutamine uptake blocks prostate cancer growth and tumour development is on the source record.
What is the PMID of Targeting <scp>ASCT2</scp>‐mediated glutamine uptake blocks prostate cancer growth and tumour development?
The PMID for Targeting <scp>ASCT2</scp>‐mediated glutamine uptake blocks prostate cancer growth and tumour development is on the source record.
What is the OpenAlex record for Targeting <scp>ASCT2</scp>‐mediated glutamine uptake blocks prostate cancer growth and tumour development?
The OpenAlex for Targeting <scp>ASCT2</scp>‐mediated glutamine uptake blocks prostate cancer growth and tumour development is on the source record.